OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial
Silvia Lanfranconi, Elisa Scola, Jennifer Meessen, et al.
The Lancet Neurology (2022) Vol. 22, Iss. 1, pp. 35-44
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial
Issam A. Awad, Roberto J. Alcazar‐Félix, Agnieszka Stadnik, et al.
The Lancet Neurology (2025) Vol. 24, Iss. 4, pp. 295-304
Closed Access | Times Cited: 1

Infantile hemangioma: the common and enigmatic vascular tumor
Annegret Holm, John B. Mulliken, Joyce Bischoff
Journal of Clinical Investigation (2024) Vol. 134, Iss. 8
Open Access | Times Cited: 7

Autonomic dysfunction and treatment strategies in intracerebral hemorrhage
Kaijiang Kang, Kaibin Shi, Jiexin Liu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 6

Cavernomi del sistema nervoso centrale
S. Guey
EMC - Neurologia (2025) Vol. 25, Iss. 1, pp. 1-10
Closed Access

Cerebral cavernous malformations – An overview on genetics, clinical aspects and therapeutic strategies
Adriana Octaviana Dulămea, Ioan Cristian Lupescu
Journal of the Neurological Sciences (2024) Vol. 461, pp. 123044-123044
Closed Access | Times Cited: 4

Genetic inactivation of the β1 adrenergic receptor prevents cerebral cavernous malformations in zebrafish
Wenqing Li, Sara McCurdy, Miguel Alejandro Lopez‐Ramirez, et al.
eLife (2025) Vol. 13
Open Access

Genetic Insights Into Hemorrhagic Stroke and Vascular Malformations: Pathogenesis and Emerging Therapeutic Strategies
Pazhanichamy Kalailingam, Kristiina Rannikmäe, Moran Hausman‐Kedem, et al.
Stroke (2025)
Closed Access

Pharmacological therapy for cerebral cavernous malformations
Rustam Al‐Shahi Salman, Michael J. Thrippleton
The Lancet Neurology (2025) Vol. 24, Iss. 4, pp. 276-277
Closed Access

Large Pontine Cavernoma with Hemorrhage: Case Report on Surgical Approach and Recovery
Corneliu Toader, Matei Serban, Lucian Eva, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2358-2358
Open Access

Developing a Randomised Efficacy PREcision medicine Platform trial design for Cavernomas: the CARE PREP study
Rustam Al‐Shahi Salman, Kasia Adamczuk, Richard A. Parker, et al.
Efficacy and Mechanism Evaluation (2025), pp. 1-21
Open Access

mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice
Lun Li, Aileen A. Ren, Siqi Gao, et al.
Stroke (2023) Vol. 54, Iss. 11, pp. 2906-2917
Open Access | Times Cited: 11

Beta-Blockers and Their Current Role in Maternal and Neonatal Health: A Narrative Review of the Literature
Andrea Martinez, Mohit Lakkimsetti, Sameep Maharjan, et al.
Cureus (2023)
Open Access | Times Cited: 9

Current and Future Treatment Options for Cerebral Cavernous Malformations
Leslie Morrison, Juan Gutierrez, Cenk Ayata, et al.
Stroke Vascular and Interventional Neurology (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 3

Clinical course of patients with conservatively managed cerebral cavernous malformations
Abel Clemens Adriaan Sandmann, Marinus A. Kempeneers, René van den Berg, et al.
European Stroke Journal (2024) Vol. 9, Iss. 3, pp. 667-675
Open Access | Times Cited: 3

Circulating biomarkers in familial cerebral cavernous malformation
Francesca Lazzaroni, Jennifer Meessen, Ying Sun, et al.
EBioMedicine (2023) Vol. 99, pp. 104914-104914
Open Access | Times Cited: 7

Transcriptomic signatures of individual cell types in cerebral cavernous malformation
Ying Li, Romuald Girard, Abhinav Srinath, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2

Patient-reported outcome measures in patients with familial cerebral cavernous malformations: results from the Treat_CCM trial
Jennifer Meessen, Giorgia Abete-Fornara, Barbara Zarino, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 2

Prevalence, genetic and clinical characteristics in first-degree relatives of patients with familial cerebral cavernous malformations in China
Chunwang Li, Lingyun Zhuo, Yaqing Kang, et al.
Stroke and Vascular Neurology (2024), pp. svn-003004
Open Access | Times Cited: 2

Kinases in cerebral cavernous malformations: Pathogenesis and therapeutic targets
Chunxiao Qi, Richard S. Bujaroski, Jonathan B. Baell, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1870, Iss. 6, pp. 119488-119488
Closed Access | Times Cited: 5

A single‐center clinical trial evaluating topical propranolol for preventing stress‐induced hair loss
Meidi Zhu, Binkai Zheng, Y S Zhang, et al.
The FASEB Journal (2024) Vol. 38, Iss. 22
Open Access | Times Cited: 1

Therapeutic Perspectives on ROCK Inhibition for Cerebral Cavernous Malformations
Tadeu L. Montagnoli, Daniela R. de Oliveira, Carlos Alberto Manssour Fraga
Kinases and Phosphatases (2023) Vol. 1, Iss. 1, pp. 72-96
Open Access | Times Cited: 4

Long-term functional outcomes and complications of microsurgical resection of brainstem cavernous malformations: a systematic review and meta-analysis
Ibrahem Albalkhi, Areez Shafqat, Othman Bin-Alamer, et al.
Neurosurgical Review (2023) Vol. 46, Iss. 1
Open Access | Times Cited: 2

Propranolol or Beta-Blockers for Cerebral Cavernous Malformation: a Systematic Review and Meta-analysis of Literature in Both Preclinical and Clinical Studies
Salman Ikramuddin, Shimeng Liu, Dylan Ryan, et al.
Translational Stroke Research (2023) Vol. 15, Iss. 6, pp. 1088-1097
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top